PCR was used to amplify and sequence the complete HA1 region of the haemagglutinin (HA)-encoding genes of 10 clinical isolates of influenza virus of the H1N1 or H3N2 subtypes. These sequences were compared to those obtained from viruses isolated from the same specimens after passage in eggs and MDCK cells.
Since it was observed that propagation of influenza viruses in eggs may lead to isolation of viruses bearing haemagglutinins (HAs) that differ in both their antigenic properties and molecular sequences from those of viruses of the same source propagated in mammalian cells (Schild et al., 1983; Robertson et al., 1985 Robertson et al., , 1987 Katz et al., 1987; Katz & Webster, 1988) , there has been concern that egg-grown viruses may not be truly representative of influenza viruses that predominate in humans. Development of the PCR technique (Mullis & Falona, 1987; Saiki et al., 1988) has made it possible to determine the molecular sequences of influenza virus genes directly from human specimens without culture of the virus in the laboratory. Using this technique, Katz et al. (1990) sequenced a 600 nucleotide region of the HA genes amplified from two influenza A (H3N2) virus-positive human specimens and found that these consensus sequences were identical to those of viruses from the same source isolated in MDCK cells, but differed in one amino acid from the HAs of the same viruses grown in eggs. Rajakumar et al. (1990) , on the other hand, reported identity between one consensus sequence obtained directly from an influenza A (H1N1) virus-positive human specimen and that from the corresponding egggrown virus. Later, Robertson et al. (1991) , using PCR followed by cloning and sequencing of individual clones to examine three influenza A (H1N1) virus clinical specimens, showed that the HA1 regions of viral populations within the clinical material and viruses grown in MDCK cells were relatively homogeneous, whereas more HA variants differing in one or two amino acids were present in virus samples grown in eggs.
Because these reports are based on analysis of relatively few specimens obtained at a single time and/or location, they require confirmation and elaboration by studies using a larger number of specimens from different patients and wider geographic distribution. Also, because virus titres obtained in MDCK cells are often low, and eggs continue to be the substrate of choice for growth of influenza viruses in large quantities, such as in vaccine production, a better understanding of the host-selected variation in the HA and of the amino acid residues that are affected is essential. Here, we report a study of 10 influenza virus clinical specimens of the H1N1 and H3N2 subtypes collected from different parts of the United States and Singapore in which we used the PCR technique to amplify and sequence the complete HA1 region of the viral HA gene. These sequences were then compared with those of viruses isolated from the same specimens after culture in eggs and MDCK cells. The 10 clinical specimens analysed, five of the H1N1 subtype and five of the H3N2 subtype, are described in Table 1 . One aliquot of each specimen was used for direct PCR amplification; whenever possible, other aliquots were immediately inoculated in MDCK cells and/or in the amniotic cavity of embryonated eggs and passaged undiluted one to three times until haemagglutination was observed. The passage history of each of the MDCK and egg isolates analysed is shown in Table 1 . Therefore, for most specimens there were three types of samples used for sequencing: original clinical material (O), MDCK cell-derived virus (M) and egg-derived virus (E). Because all the specimens from Singapore (H1N1 and H3N2) and the one from Hawaii did not grow directly in eggs after three passages, egg isolates were derived by subsequent passage of the MDCK isolates in eggs. We could not obtain MDCK isolates suitable for sequencing analysis from specimens SN12/89 and SN13/89 because these specimens did not grow in MDCK cells or eggs. It is probable that virus within the original specimen had been inactivated during shipment or storage at -70 °C. Egg-derived HA1 sequences from both samples were determined from frozen allantoic fluids obtained previously.
RNA was extracted as described ) from pelleted viruses in clinical material or tissue culture fluid which had been previously concentrated from 0.2 to 0"8 ml samples by ultracentrifugation at 35000 r.p.m, for l h in a Beckman L5-50 ultracentrifuge, using a SW50.1 rotor and Beckman ultraclear minitubes (5 x 61 mm) with adaptors. For egg isolates, viral RNA (vRNA) was extracted directly from 0.35 ml of allantoic fluid, cDNA synthesis and PCR amplification of the HA1 region of the HA gene were carried out using, for the H3 subtype, forward primer 7 (5' d-ACTATCATTGCTTTGAGC, mRNA sense) and reverse primer Rl184 (5'd-ATGGCTGCTTGAGTGCTT, vRNA sense), and for the H1 subtype, forward primer 6 and reverse primer Rl193 (described in Xu et al., 1993) . For reverse transcription, the precipitated RNA was resuspended in 25 gl of 4xPCR buffer (Cetus-Perkin Elmer), 25 Units (U) RNase inhibitor (Boehringer Mannheim), 800 gN-dNTPs, 0.5 Ixg (100 pmol) of forward primer, and 25 U avian myeloblastosis virus reverse transcriptase (Life Sciences). After incubation at 42 °C for 1 h, the cDNA was diluted to 100 gl with sterile endotoxin-free distilled water containing 0-5 gg of reverse primer and 2.5 U of Taq DNA polymerase (Cetus). PCR was carried out in a Perkin-Elmer Cetus thermal cycler programmed for one cycle with denaturation for 5 min at 94 °C, and 25 cycles of 1 min at 94 °C, 2 min at 50 °C, and 3 rain at 72 °C. The PCR product of the expected size (approximately 1100 bp) was purified on 1% agarose gels as described (Xu et al., 1993) . HA1 sequences were determined directly, without cloning, from the purified PCR-amplified material which was enriched in ssDNA by performing an asymmetric PCR using an input primer ratio of 100:1. The procedures for asymmetric PCR, sequencing, and computer analysis of the sequence data have been described previously (Klimov et aL, 1992; Rocha et al., 1991) . Four internal primers complementary to the viral mRNA strand were used to sequence the H3 HA:
The primers used to sequence the H1 HA1 have been described previously (Xu et al., 1993) . All extractions and amplifications included negative controls. To avoid contamination between types of isolates, care was taken not to work with MDCK-or egg-grown virus and the corresponding clinical specimen at the same time. Each of the clinical specimens was found to have unique nucleotide sequences, indicating that contamination of one sample by another had not occurred.
Comparisons of the deduced amino acid sequences of the HA1 region for the H1 and H3 specimens are shown in Fig. 1 (a) and (b) , respectively. Fig. 1 (a) shows that all the H 1 egg-derived HA sequences differed by at least one amino acid from the HA sequence derived directly from the clinical specimen. SN03/90, SN06/90, SN10/90 and SN12/90 each had a single substitution at residues 227 (Glu to Arg), 226 (Gln to Arg), 196 (His to Arg) and 225 (Asp to Gly), respectively. SNll/90 was the only specimen that exhibited two substitutions, at residues 225 (Asp to Asn) and 77a (Ser to Leu). On the other hand, the MDCK-derived HAs were identical to those of the original specimens with one exception: sample SN10/90 grown in MDCK cells exhibited the same substitution at residue 196 (His to Arg) as its egg-grown counterpart. Fig. 1 (b) shows that three of the H3 egg-derived HAs differed by a single amino acid substitution from the human-derived sequence. SN13/89 and IN01/90 each had an amino acid change at residue 186 (Ser to Ile), and specimen HI01/91 had a change at residue 156 (Glu to Lys). The egg-derived HA1 sequence of SD01/91, however, contained no substitutions and was identical to the HA1 of the virus within the human specimen. In contrast, the egg-derived HA of specimen SN12/89 exhibited four amino acid differences from the HA in the corresponding clinical material, one at position 186 (Set to Ile) and three additional ones at positions 137 (Cys to Tyr), 248 (Ile to Thr) and 276 (Ile to Thr). MDCKderived HA sequences of the H3 specimens were determined only for IN01/90, HI01/91 and SD01/91 because SN12/89 and SN13/89 did not grow in tissue culture (see above) and they were found to be identical to the HA sequences from the original specimen.
The amino acid differences exhibited by specimen SN12/89 are unusual because of the nature of the amino acids found in the HA within the clinical material, Cys at position 137 and Ile at positions 248 and 276. Although the presence of these amino acids was observed in reference strain VC0589 (Fig. 1 b) , all the HAs in the clinical material analysed in this study and by others (Katz et aL, 1990) as well as most of the field strains sequenced to date (Both et aL, 1983 ; N. J. Cox, unpublished results) have Tyr at position 137 and Thr at positions 248 and 276. Furthermore, the presence of Ile at residue 248 has been associated with adaptation in eggs (Katz et al., 1990) . These amino acids were not detected in the egg-derived HA. In this instance, growth of the virus in eggs appears to have selected against certain amino acids that exist in the HA of the clinical specimen.
Most of the egg-selected amino acid changes (except at 77a in the H1 HA and 276 in the H3 HA) could be located in the vicinity of the receptor-binding pocket Weiss et aL, 1988) and also could be assigned to antigenic sites of the molecule Caton et al., 1982) . However, haemagglutination inhibition tests using six post-infection ferret sera, each made with different influenza viruses, detected differences in antigenic properties only between the egg-and MDCK-grown A/Hawaii/01/91 virus pair, which differ at residue 156 (data not shown).
Substitutions at residues 225 and 226 in the H1 HA, and 156, 186 and 248 in the H3 HA, had already been described as being associated with adaptation to growth in eggs (Robertson et al., 1991 ; Katz et al., 1990) . In this study we have identified additional amino acid substitutions at H1 HA residues 77a, 196 and 227 and at H3 HA residues 137 and 276. The change at residue 77a may not have been selected by growth of the virus in eggs because it is not near the receptor-binding pocket and occurred in association with a change at amino acid 225.
The presence of Lys at H3 HA position 145 had been identified previously as being egg-selected (Katz & Webster, 1988; Wang et al., 1989) . However, we observed that original specimens SD01/91 and HI01/91 had a Lys at residue 145 (Fig. l b) , indicating that this change, which is also found in the 1992/93 vaccine strain BE35389 and other recent field isolates (Fig. l b) , is a mainstream evolutionary change and it is not selected for by growth in eggs. This demonstrates that specific amino acid changes that are, in some cases, egg-selected may also be selected because of immune pressure. This is not surprising because of the close proximity of the antigenic and receptor-binding sites of the virus (Weiss et al., 1988) . In addition, given the quasispecies nature of RNA viral genomes (for review, see Domingo & Holland, 1988) , considerable variation in the genomes of influenza viruses should be expected. Any change in environmental conditions may offer previously disadvantaged variants the opportunity to compete favourably with the predominant virus and shift the equilibrium of variant genomes. Both the immune response and the ability of the virus to infect different host organisms and different cells within one organism are key factors that promote modifications in the equilibrium distribution of genomes (Domingo, 1989) . The results presented in this study agree with the work of others (Katz et al., 1990; Robertson et al., 1991) that growth of human influenza virus in chicken eggs often selects for subpopulations of the virus bearing HAs that differ in one or more amino acids from the predominant sequence of the virus found replicating in humans, whereas propagation of influenza viruses in MDCK cells, in general, does not. However, we have shown here that an egg-grown virus of the H3N2 subtype provided virus stocks identical to the virus replicating in humans, in accordance with the findings of Rajakumar et al. (1990) , and that the HA sequence of MDCK-grown virus may also differ from the sequence of the predominant human virus. In addition, we demonstrate that an amino acid change at residue 145 in the HA of the H3 subtype that was previously shown to be associated with growth in eggs is now present in circulating strains. Host selection of variants in the laboratory is a significant consequence of the quasispecies structure of RNA viruses. It is important, therefore, carefully to monitor the virus isolated after any kind of manipulation in vitro to ensure its identity with the initial virus stocks.
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